Oxytocin 2mg For Promote Labor CAS:50-56-6

   What It Is: Mimicking Nature's Master Conductor

    ●Molecular Essence: Oxytocin is a nonapeptide hormone – a chain of nine amino acids – identical in structure to the endogenous oxytocin produced by the posterior pituitary gland in the brain. This structural fidelity is crucial for its function.

    ●The 2mg Formulation: This represents a highly concentrated pharmaceutical preparation (typically 10 IU/mL when diluted as per protocol). The "2mg" label is somewhat historical/conventional; biologically, oxytocin is measured in International Units (IU), with 1 mg roughly equivalent to approximately 500 IU. Therefore, a 2mg vial contains about 1000 IU of oxytocin. This high concentration allows for precise, controlled dilution and administration via intravenous infusion, enabling minute titration.

    ●Core Purpose: Oxytocin 2mg solution is exclusively indicated for the medical induction or augmentation of labor in specific clinical scenarios. It is not a standalone treatment; it's a powerful tool requiring expert medical supervision within a hospital setting equipped for continuous maternal and fetal monitoring.  

 

 

    1.High Concentration for Precise Titration: The 2mg (1000 IU) vial is deliberately concentrated. This allows clinicians to dilute it significantly (e.g., 2mg in 1000ml of IV fluid = 1 IU/mL) creating a solution where minute adjustments to the infusion rate (mL/hour) translate into precise, incremental changes in the dose delivered (mIU/minute). This precision is paramount for safety.

    2.Uterine Myometrium Specificity: Oxytocin's primary target is the smooth muscle cells (myometrium) of the pregnant uterus. It binds to highly specific oxytocin receptors densely expressed on these cells, particularly near term. This binding triggers a cascade leading to increased intracellular calcium, the fundamental driver of muscle contraction.

    3.Receptor Upregulation: A critical physiological feature leveraged pharmacologically is that endogenous oxytocin and uterine stretch upregulate (increase the number of) oxytocin receptors on the myometrium as pregnancy progresses and labor approaches. This makes the uterus increasingly sensitive to oxytocin's effects near term, a key reason why it's effective for induction/augmentation at that stage.

    4.Pulsatile Nature Requirement: Effective labor contractions are inherently pulsatile – they build, peak, and subside, allowing vital blood flow to the placenta and fetus in between. Intravenous oxytocin infusion aims to mimic this physiological pulsatility. Continuous, unmodulated stimulation would be dangerous and ineffective. The titrated IV drip is designed to replicate this natural rhythm.

    5.Sensitivity Variability: A crucial feature demanding careful management is the significant variation in individual uterine sensitivity to oxytocin. Factors include parity (previous births), gestational age, cervical readiness, and whether labor has already started. There is no universal "effective dose"; dosing is highly individualized and requires constant adjustment based on response.

    Oxytocin 2mg is employed in specific, carefully assessed situations:

    1.Labor Induction: Initiation of contractions before spontaneous onset, medically justified when:

    ○Prolonged pregnancy (post-term: ≥41+0 to 42+0 weeks, depending on guidelines).

    ○Premature Rupture of Membranes (PROM) without spontaneous labor onset.

    ○Maternal medical conditions (e.g., preeclampsia, diabetes, chronic hypertension) where continuing pregnancy poses risks.

    ○Significant fetal concerns (e.g., severe growth restriction, deteriorating fetal well-being).

    ○Requires a favorable ("ripe") cervix (Bishop score assessment) or prior cervical ripening agents (e.g., prostaglandins).

    2.Labor Augmentation: Strengthening inadequate, inefficient, or arrested contractions in an already established labor:

    ○Protracted active phase (slow cervical dilation despite contractions).

    ○Arrest of descent (fetal head not progressing down the birth canal).

    ○Hypotonic uterine dysfunction (weak, infrequent, or short contractions).

    ○Crucially, augmentation requires confirmation of true labor and the absence of cephalopelvic disproportion (CPD).

    The benefits of judicious oxytocin use are significant, but always weighed against risks:

    1.Achieving Vaginal Delivery: When spontaneous labor stalls or poses risks by not starting, oxytocin offers a pathway to achieve vaginal birth, often preferred over cesarean section when safe and appropriate.

    2.Reducing Prolonged Labor Risks: By effectively augmenting contractions, oxytocin can shorten excessively long labors, mitigating risks associated with maternal exhaustion, infection (especially after PROM), and fetal compromise (e.g., acidemia).

    3.Mitigating Post-Term Risks: Induction using oxytocin helps avoid the increased risks of stillbirth, meconium aspiration, macrosomia, and placental insufficiency associated with pregnancies extending significantly beyond term.

    4.Managing Maternal Conditions: Allows for timely delivery when maternal health conditions necessitate ending the pregnancy for the mother's well-being.

    5.Potential Reduction in Cesarean for Failure to Progress: When arrest is due to inadequate contractions without true obstruction (CPD), successful augmentation can prevent a cesarean section that might otherwise be performed.

    Crucial Principle: Oxytocin 2mg is NEVER administered as a bolus (rapid injection). It is ALWAYS diluted and given as a carefully controlled and titrated intravenous infusion.

    1.Dilution: The standard dilution involves adding 2mg (1000 IU) oxytocin to 1000ml of an isotonic IV solution (like Normal Saline or Lactated Ringer's). This creates a concentration of 1 IU per mL. Alternative dilutions (e.g., 1mg/500ml = 2 IU/mL) are sometimes used but require meticulous calculation to avoid dosing errors.

    2.Starting Dose: Initiation is extremely conservative, typically 0.5 - 1.0 mIU/minute (milli-International Units per minute). This equates to 0.5 - 1.0 mL/hour of the standard 1 IU/mL dilution.

    3.Titration Protocol: The dose is increased incrementally at regular intervals (commonly every 30-60 minutes). Increments are usually small (e.g., 1-2 mIU/minute). The goal is to achieve adequate labor progress defined by:

    ○Cervical dilation of approximately 1 cm per hour in the active phase.

    ○Establishment of a regular contraction pattern: 3-5 contractions in 10 minutes, each lasting 40-60 seconds, with a palpable return of uterine tone between contractions.

    ○Satisfactory fetal heart rate pattern (no non-reassuring signs).

    4."Effective Dose" & Ceiling: There is no fixed effective dose. The dose is increased only until adequate labor progress is achieved without causing uterine hyperstimulation or non-reassuring fetal status. Doses rarely need to exceed 20 mIU/minute, and often much lower doses (e.g., 6-12 mIU/min) are sufficient. Higher doses increase risks without proven benefit and may indicate underlying issues like CPD.

    5.Continuous Monitoring: Mandatory throughout administration includes:

    ○Continuous Electronic Fetal Monitoring (EFM): To detect fetal heart rate abnormalities instantly.

    ○Uterine Activity Monitoring: Via tocodynamometer or intrauterine pressure catheter (IUPC) to quantify contraction frequency, duration, intensity, and resting tone.

    ○Maternal Vital Signs: Regular checks for blood pressure, pulse, and fluid balance.

    6.Discontinuation: Oxytocin is stopped immediately for:

    ○Uterine hyperstimulation (excessive contractions: >5 in 10 min, lasting >90 sec, insufficient resting tone).

    ○Non-reassuring fetal heart rate patterns.

    ○Delivery of the baby.

    ○Suspected uterine rupture (rare but catastrophic).

    ○Maternal intolerance (e.g., severe hypotension, allergic reaction).

    ●Pharmacokinetic Cycle: Administered via IV infusion, oxytocin enters the bloodstream directly. Its effects on the uterus are rapid, usually observable within minutes of starting or changing the infusion rate. Its short half-life (see below) allows for equally rapid cessation of effect once the infusion is stopped or reduced. This forms a dynamic cycle: Infusion Rate Change -> Plasma Concentration Change -> Uterine Receptor Binding -> Contraction Pattern Change -> Clinical Assessment -> Further Infusion Rate Adjustment. This cycle repeats constantly throughout administration.

    ●Goal: Physiologic Pattern: The entire titration process aims to create a contraction pattern indistinguishable from effective spontaneous labor – regular, strong, with distinct peaks and troughs allowing for uteroplacental perfusion.

    ●Short Plasma Half-Life: Oxytocin has an exceptionally short plasma elimination half-life, estimated at approximately 3-17 minutes in pregnant women near term. This means that half of the oxytocin circulating in the bloodstream is cleared roughly every 3-17 minutes.

    ●Critical Implications:

    1.Rapid Onset & Offset: Effects begin quickly after starting the infusion. Crucially, if hyperstimulation or fetal distress occurs, stopping the infusion leads to a rapid decline in plasma levels and, consequently, a rapid decrease in uterine stimulation. This short half-life is the fundamental pharmacological property that makes titrated IV infusion feasible and relatively safe. The drug's effect dissipates quickly when administration ceases.

    2.Titration Necessity: Because levels drop so fast, a continuous infusion is required to maintain therapeutic plasma concentrations. The short half-life necessitates the incremental titration approach to gradually find the minimal effective dose without overshooting.

    3.No Cumulative Effect: Due to rapid clearance, oxytocin does not accumulate in the body with prolonged infusion at a steady rate. However, receptor saturation at the myometrium can occur with high doses.

Trade names	Oxt or OT, OT-NPI, OXT-NPI, oxytocin,Pitocin
CAS	50-56-6
Molar mass	1007.19
Formula	C43H66N12O12S2
Purity	Above 98%
Apprarance	2mg/vial,Lyophilized powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    Oxytocin 2mg is far more than just a "labor drug." It is a potent pharmaceutical tool that meticulously replicates the action of a fundamental natural hormone. Its high-concentration formulation enables the precise, titrated intravenous administration required to safely stimulate the uterus. Its benefits in facilitating vaginal delivery and managing prolonged pregnancies or dysfunctional labor are significant, but they are inextricably linked to its inherent risks, primarily uterine hyperstimulation and potential fetal compromise.

    The short half-life is its saving grace, allowing for rapid intervention if problems arise. However, this very characteristic demands constant vigilance, expert titration based on individual response, and unwavering adherence to protocols mandating continuous maternal and fetal monitoring. The successful and safe use of Oxytocin 2mg hinges entirely on the clinician's understanding of its unique pharmacology, the physiology of labor, the art of titration, and the readiness to act decisively at the first sign of trouble. It is a testament to medical science's ability to harness nature's mechanisms, but one that requires the utmost respect and skill to wield effectively.

Hot Tags: oxytocin 2mg for promote labor cas:50-56-6, China oxytocin 2mg for promote labor cas:50-56-6 manufacturers, suppliers, factory